• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Visual acuity after intravitreal ranibizumab with and without laser therapy in the treatment of macular edema due to branch retinal vein occlusion: a 12-month retrospective analysis

    2021-11-08 01:45:30ReikoUmeyaKoichiOnoToshimitsuKasuga
    International Journal of Ophthalmology 2021年10期

    Reiko Umeya, Koichi Ono, Toshimitsu Kasuga

    1Department of Ophthalmology, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo 136-0075, Japan

    2Department of Ophthalmology, Juntendo University School of Medicine, Tokyo 113-8421, Japan

    Abstract

    ● KEYWORDS: interaction; ranibizumab; laser; macular edema; branch retinal vein occlusion

    INTRODUCTION

    Since it was first described in 1984, laser photocoagulation has been used to treat macular edema (ME) associated with branch retinal vein occlusion (BRVO)[1]. More recently,the BRAVO study, which investigated the treatment of ME following BRVO[2-3], showed that intravitreal injection of the vascular endothelial growth factor (VEGF) inhibitor ranibizumab (IVR) was a safe and effective treatment for BRVO-associated ME. This treatment has also been widely used in Japan, where it was approved for coverage under the National Health Insurance system in August 2013.The BRIGHTER study showed that at six months after commencing treatment, IVR with or without laser therapy was significantly better in terms of efficacy and safety than laser therapy alone[4-5]. The multicenter investigations conducted to date point to intravitreal anti-VEGF therapy as a reasonable first-choice treatment for BRVO-associated ME. However,most prospective randomized controlled trials to date have been sponsored by the pharmaceutical industry. In the BRAVO study, patients in the 0.5 mg ranibizumab group underwent an average of 8.4 intravitreal injections per year[3]; in clinical practice, such frequent intravitreal injections would place a heavy economic burden on the patient. Another prospective study examined combined treatment with macular grid photocoagulation and anti-VEGF drugs to reduce the number of intravitreal injections per patient; however, the combination did not affect visual acuity[6]. Despite this, 14/39 (35.9%)retinal experts in clinical practice in Japan opted for anti-VEGF and laser therapy in patients with recurrent ME due to BRVO[7].This suggests that, at least in some cases, combination therapy may have some beneficial effects. Therefore, the purpose of the present study was to assess the interaction between laser therapy and IVR retrospectively.

    SUBJECTS AND METHODS

    Ethical Approval Each patient provided written informed consent before treatment with laser, sub-Tenon’s capsule injection of triamcinolone (STTA), or IVR at our hospital. The study protocol was reviewed and approved by the Institutional Ethics Committee. This study was conducted in accordance with the Declaration of Helsinki, and no personal information is reported.

    Study Design and Patients This retrospective, observational,single-institution, case-comparison series was performed to analyze visual outcomes 1y after treatment of ME secondary to BRVO. We reviewed outpatient clinical records between June 2002 and June 2019, searching for data using the diagnostic term “retinal vascular occlusion” (International Classification of Diseases-10 code H34). Patients seen at our hospital from June 2002 to June 2019 were included if they met the following criteria: 1) a diagnosis of retinal vascular occlusion; 2) fluorescein angiography (FA) and/or optical coherence tomography (OCT)of the fundus; 3) at least 12mo of follow-up; 4) presence of ME. Exclusion criteria were 1) incorrect diagnosis or incomplete clinical record; 2) central retinal vein occlusion;3) follow-up of less than 12mo; 4) intravitreal bevacizumab injection (IVB); 5) intravitreal aflibercept injection (IVA).

    Clinical Analysis and Outcome Measures BRVO-associated ME was diagnosed based on FA and/or OCT findings.All subjects underwent comprehensive ophthalmological examination, including best corrected visual acuity (BCVA),retinal structure evaluation using FA (Topcon Medical Systems, Inc., Oakland, New Jersey, USA), and/or OCT(Cirrus high-definition OCT; carl Zeiss, Dublin, CA, USA).The reported therapeutic outcome was based on change in visual acuity between initial presentation and 12-month follow-up. BCVA was measured at 5 m on a standard Japanese fractional visual acuity chart (Distant Test Chart, LANDOLT,Handaya, Tokyo, Japan). The logarithmic minimal angle of resolution (logMAR) was calculated from the decimal visual acuity. OCT was introduced in August 2008, and we quantified the fovea thickness in subsequent cases. Possible confounding factors for visual outcomes were selected in accordance with results from previous studies and included age[8], history of systemic hypertension, diabetes mellitus[9], current or past smoking history, and foveal hemorrhage[10]. A history of systemic hypertension, diabetes mellitus, and/or smoking was established from the clinical records.

    Treatments After diagnosis of ME associated with BRVO,informed consent was obtained from each patient, and treatment provided at the discretion of each doctor. Treatment methods included laser therapy, IVR (Lucentis?, 0.5 mg in 0.05 mL; Genentech, San Francisco, CA, USA), sub-Tenon’s capsule injection of triamcinolone (STTA; Kenacort?, 20 mg; Bristol-Myers Squibb, Princeton, NJ, USA)[11], or a combination thereof, as well as some cases that were observed without intervention. Coagulation conditions requiring local coagulation for blood vessel dilation, and grid coagulation for diffuse leakage, were at the discretion of each doctor and considered laser treatment in the present study. Since 2013,when ranibizumab was approved for insurance in Japan, IVR has been implemented for OCT with central retinal thickness over 300 μm. Combination therapy was administered at the discretion of each doctor.

    Statistical Analysis Visual acuity and central foveal thickness (CFT) were expressed as mean±standard deviation(SD). Decimal acuity was converted to logMAR units for statistical analysis. A pairedt-test was performed to evaluate the difference in visual acuity before and after treatment.Multivariate logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI). Age, sex, history of hypertension, diabetes mellitus, smoking history, and foveal hemorrhage were considered confounders. We examined the interaction of treatment methods that contributed to the improvement in visual acuity by using multivariate Logistic regression analysis with the interaction terms.P<0.05 was considered statistically significant. All statistical analyses were performed in STATA/SE 15.1 for windows (Stata Corp.,College Station, TX, USA).

    RESULTS

    Baseline Characteristics and Patient Demographics A patient selection flowchart for this study is shown in Figure 1.We included patients diagnosed with retinal vascular occlusion at our hospital from June 2002 to June 2019. From 555 records identified, we excluded records with errors in registration or documentation on clinical charts (n=60); patients with central retinal vein occlusion (n=174), late-stage BRVO (n=129),BRVO without ME (n=30), and BRVO with <12mo of followup (n=55), patients who received IVB (n=33), and patients who received IVA (n=1). Detailed patient profile and treatment history is presented in Table 1. We included 73 patients (34 men, 39 women; 73 eyes) with BRVO-associated ME, aged 33-93y (mean±SD, 69.4±12.1y). Twenty patients received laser monotherapy, 12 received IVR monotherapy, 4 received STTA monotherapy, 4 received IVR+STTA, 8 received IVR+laser,4 received STTA+laser, and 3 received IVR+STTA+laser.Eighteen patients were observed who did not receive treatment throughout the follow-up period.

    Figure 1 Subject selection flowchart Patients seen at our hospital from June 2002 to June 2019 were included if they had a diagnosis of retinal vascular occlusion. BRVO: Branch retinal vein occlusion;CRVO: Central retinal vein occlusion; ME: Macular edema.

    Table 1 Clinical characteristics in patients with BRVO mean±SD

    Visual Acuity and Central Foveal Thickness Table 2 shows the course of visual acuity and central retinal thickness for each treatment. Dunn’s multiple-comparison test for stochastic dominance using Bonferroni correction, showed no difference in BCVA among groups at baseline. The BCVA in the IVR monotherapy, laser monotherapy, and STTA+laser groups were significantly increased (P<0.001, <0.001, and =0.019,respectively). OCT was performed in 38 of 73 cases (52.1%)with a significant reduction in CFT at 12mo (317.2±165.1vs537.6±197.5 μm,P<0.0001). Table 2 shows visual acuity and central foveal thickness at baseline and after treatment in each group.

    Factors Associated with Visual Acuity Improvement Table 3 shows the ORs of each predictor of visual acuity improvement. In simple Logistic regression models, the factor associated with visual improvement was IVR (crude OR:3.05, 95%CI: 1.12-8.30,P=0.029). After adjusting for all other variables, IVR remained the significant factor (adjusted OR:3.89, 95%CI: 1.25-12.1,P=0.019). There was no significant interaction between laser and IVR (adjusted OR: 0.07, 95%CI:0.01-0.75,P=0.029; Table 4).

    DISCUSSION

    Our retrospective analysis of visual outcomes after 12mo in patients treated for ME due to BRVO showed that laser and IVR improved visual acuity; however, there was no significant interaction between these treatments. Before the introduction of anti-VEGF therapy, grid laser photocoagulation was the standard treatment for ME due to BRVO[1]. Today, anti-VEGF therapy is widely accepted as the treatment of choice for BRVO-associated ME, based on prospective randomized controlled trials[2-4].

    Two previous large retrospective cohort studies[12-13]have described visual improvements after anti-VEGF treatment.Within these cases, a small number (23/205[12]and 20/177[13])received laser therapy in combination with anti-VEGF treatment, but the interaction of these treatments was not analyzed statistically. The BRAVO study[3]prospectively compared visual outcomes after treatment between two groups; grid laser photocoagulation was used in 20% of the IVR group and 55% of the sham group. However, the study did not examine whether grid laser photocoagulation combined with IVR had any therapeutic effects. In another study, Tanet al[14]compared the efficacy of IVR for BRVO-associated ME for 12mo between patients who received IVR for six consecutive months then as needed for another six months, and patients who received sham injections for 12mo. Grid laser photocoagulation was performed at 13 and 25wk in 2 of 15 cases in the IVR group, and in all 21 cases of the sham group.Their results showed that, compared to the sham group, the IVR group exhibited significant and sustained improvements invisual acuity and anatomical outcomes after 12mo of treatment.However, they could not demonstrate that the combination of laser and ranibizumab therapy resulted in higher efficacy than ranibizumab monotherapy. In the RELATE study,subjects randomly assigned to treatment with 0.5 or 2.0 mg of ranibizumab every 4wk for 24wk were then re-randomized to receive only ranibizumab+laser orpro re nataranibizumab[15].Significant improvements in BCVA were reported within the first two years in the group that received additional laser treatment, but this significance disappeared in later follow-ups.The authors concluded that the addition of laser therapy neither increased edema resolution nor reduced the total number of ranibizumab injections, so there was no long-term benefit. In the BRIGHTER study[4], one group received IVR injections for at least three consecutive months initially, followed by an asneeded regimen, and was compared with an IVR+laser group and a laser monotherapy group; the IVR groups, with or without laser, showed significantly better visual results after six months than the laser monotherapy group, with no difference between the IVR and IVR+laser groups. In other words, the beneficial effects of additional laser therapy could not be demonstrated.Overall, these randomized controlled trials[3-4,14-15]indicated that adding laser treatment to IVR had no beneficial effect on BRVO edema. However, a combination of IVB and laser photocoagulation was reported to reduce the number of bevacizumab doses[16], although the interaction between IVR and laser treatment had not been studied to date.

    Table 2 Change in visual acuity and central retinal thickness from baseline to 12mo mean±SD

    Table 3 Odds ratios of visual acuity recovery obtained by Logistic regression analysis without interaction terms

    Table 4 Adjusted odds ratios using an interaction model

    The strength of the present study is the inclusion of patients across the time period when laser treatment was the main treatment focus and the current time period when anti-VEGF treatment is the main focus. Therefore, by including patients treated with laser monotherapy before the introduction and approval of the anti-VEGF drug ranibizumab (Lucentis?),the likelihood of selection bias is reduced. As a result, in the Logistic analysis model without interaction terms, the factor related to visual acuity improvement was IVR, with no interaction between laser and IVR. The reason for this may be that our study included cases with long-duration ME before intervention, as well as cases of severe, refractory, and recurrent ME, reflecting real-world clinical conditions.

    There are some limitations to our study, including the retrospective nature of the study. At our hospital (Juntendo Tokyo Koto Geriatric Medical Center), our patients have an older demographic, and it is difficult to conduct prospective clinical trials due to cognitive decline and physical dysfunction.Another limitation is the use of clinical records, with a strong possibility of introducing bias due to deficits in documentation and history-taking as well as patient misclassification. Also,selection bias may have been introduced as patients and ophthalmologists were not blinded to the treatment assigned,with more patients with poor response to laser monotherapy being assigned to IVR+laser. In addition, various types of laser treatment were included, and it was sometimes difficult to determine from medical records whether a grid laser,non-perfusion area laser, or both, had been used. Although a randomized controlled trial would be ideal, the doubleblind method would require the use of ethically questionable methods such as sham vitreous injection or sham laser, and unlike traditional treatments does not respect the patient’s self-determination. Last, the sample size was small (n=73).This is because older patients are difficult to follow for more than 12mo, and this study does not include patients treated with IVB or IVA. Due to the small sample size, we had to reduce the number of confounding factors. Previous studies included ethnicity, high hematocrit[17-18], and the presence of hyperlipidemia, cardiovascular disease, apoplexy, renal disease, sleep apnea syndrome[19], and primary open-angle glaucoma[20]. Other studies showed that factors related to poor visual outcome were age, time to disease onset, visual acuity at initiation of treatment[5], and the presence of sub-foveal hemorrhage[9]. The small sample size in the present study was likely insufficient to test the effects of these all potential confounding factors.

    In conclusion, IVR therapy significantly improved the visual acuity of patients with BRVO-associated ME, and no interaction was observed between laser and IVR therapies.However, in routine clinical situations, ME can recur after IVR therapy, and in some cases requires laser photocoagulation.In future studies, it would be worth identifying factors associated with lower doses and shorter duration of anti-VEGF administration, and even those associated with ultimate treatment cessation.

    ACKNOWLEDGEMENTS

    Conflicts of Interest:Umeya R, None; Ono K, None;Kasuga T, None.

    欧美区成人在线视频| 欧美成人a在线观看| 亚洲精品日本国产第一区| 丝瓜视频免费看黄片| 日日摸夜夜添夜夜添av毛片| 日韩人妻高清精品专区| a级毛片免费高清观看在线播放| 亚洲欧洲国产日韩| 日韩成人av中文字幕在线观看| 最近2019中文字幕mv第一页| 久久久欧美国产精品| 日韩欧美 国产精品| 99热网站在线观看| 高清欧美精品videossex| 免费黄网站久久成人精品| 亚洲人成网站在线观看播放| 成人毛片60女人毛片免费| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 少妇熟女欧美另类| 国产毛片在线视频| 自拍偷自拍亚洲精品老妇| 国产亚洲午夜精品一区二区久久 | 神马国产精品三级电影在线观看| 我要看日韩黄色一级片| 国产亚洲av嫩草精品影院| 99久久人妻综合| 99久久九九国产精品国产免费| 日本与韩国留学比较| 国产精品爽爽va在线观看网站| 简卡轻食公司| 午夜视频国产福利| 婷婷色麻豆天堂久久| 精品久久国产蜜桃| 99热6这里只有精品| 国产探花在线观看一区二区| 男女边摸边吃奶| 精品久久国产蜜桃| 欧美丝袜亚洲另类| 日韩,欧美,国产一区二区三区| 国产精品福利在线免费观看| 亚洲,一卡二卡三卡| 蜜桃亚洲精品一区二区三区| 国产白丝娇喘喷水9色精品| 看非洲黑人一级黄片| 嫩草影院新地址| 女人被狂操c到高潮| 人妻一区二区av| 欧美亚洲 丝袜 人妻 在线| 久久久久久久午夜电影| 麻豆精品久久久久久蜜桃| 午夜免费男女啪啪视频观看| 亚洲激情五月婷婷啪啪| 国产综合精华液| 美女高潮的动态| 日韩成人伦理影院| 少妇丰满av| 亚洲欧美日韩卡通动漫| videos熟女内射| 精品国产一区二区三区久久久樱花 | 99精国产麻豆久久婷婷| 中文精品一卡2卡3卡4更新| 久久国内精品自在自线图片| 亚洲av中文字字幕乱码综合| 自拍偷自拍亚洲精品老妇| 久久综合国产亚洲精品| 中文字幕亚洲精品专区| 国产av码专区亚洲av| 亚洲av.av天堂| 亚洲综合精品二区| 丝袜喷水一区| 男女边摸边吃奶| 亚洲最大成人av| a级毛色黄片| 国产伦在线观看视频一区| 日本与韩国留学比较| 日韩成人av中文字幕在线观看| 美女视频免费永久观看网站| 欧美日韩综合久久久久久| 国产成人91sexporn| 能在线免费看毛片的网站| 观看免费一级毛片| 亚洲精品自拍成人| 久久99热这里只频精品6学生| 女的被弄到高潮叫床怎么办| 欧美区成人在线视频| 黑人高潮一二区| 国产精品熟女久久久久浪| 日韩视频在线欧美| 日本与韩国留学比较| 日本爱情动作片www.在线观看| 欧美日韩亚洲高清精品| 熟女电影av网| 国产黄a三级三级三级人| 亚洲人与动物交配视频| 国产毛片a区久久久久| 精品国产三级普通话版| 亚洲精品日本国产第一区| 国产伦精品一区二区三区四那| 亚洲精品亚洲一区二区| 美女xxoo啪啪120秒动态图| 免费看av在线观看网站| 国产成人精品福利久久| 国产精品一及| 成年人午夜在线观看视频| 精品久久久久久久人妻蜜臀av| freevideosex欧美| 大片免费播放器 马上看| 久久精品国产亚洲av天美| 最近中文字幕2019免费版| 亚州av有码| 国产淫片久久久久久久久| 小蜜桃在线观看免费完整版高清| 蜜臀久久99精品久久宅男| 中国国产av一级| 国产精品伦人一区二区| www.av在线官网国产| 亚洲伊人久久精品综合| 最近2019中文字幕mv第一页| 波多野结衣巨乳人妻| 国产免费一级a男人的天堂| 熟女电影av网| 国产黄色视频一区二区在线观看| 夜夜爽夜夜爽视频| 国产成人精品久久久久久| 国产精品久久久久久精品电影| 亚洲精品影视一区二区三区av| 日本三级黄在线观看| 91狼人影院| 亚洲真实伦在线观看| 国国产精品蜜臀av免费| 婷婷色综合www| 丝袜喷水一区| 成年版毛片免费区| 免费播放大片免费观看视频在线观看| 日本wwww免费看| av在线天堂中文字幕| 在现免费观看毛片| 亚洲人成网站在线播| 麻豆成人午夜福利视频| 好男人在线观看高清免费视频| 亚洲精品中文字幕在线视频 | 精品人妻偷拍中文字幕| 亚洲成人中文字幕在线播放| 国产一区亚洲一区在线观看| 亚洲aⅴ乱码一区二区在线播放| 乱系列少妇在线播放| 欧美 日韩 精品 国产| 赤兔流量卡办理| 人妻一区二区av| 亚洲精品久久久久久婷婷小说| 少妇丰满av| 青青草视频在线视频观看| 免费看日本二区| 精品国产一区二区三区久久久樱花 | 国产永久视频网站| 亚洲欧美日韩卡通动漫| 午夜视频国产福利| 国产成人免费观看mmmm| 亚洲人与动物交配视频| 人体艺术视频欧美日本| 青春草亚洲视频在线观看| 欧美 日韩 精品 国产| 夜夜看夜夜爽夜夜摸| 丰满乱子伦码专区| 中文字幕亚洲精品专区| 男女边摸边吃奶| 久久97久久精品| 最近最新中文字幕大全电影3| 中文天堂在线官网| 毛片一级片免费看久久久久| 熟女av电影| 草草在线视频免费看| 国产精品嫩草影院av在线观看| 欧美高清成人免费视频www| 3wmmmm亚洲av在线观看| 国产黄色视频一区二区在线观看| 美女脱内裤让男人舔精品视频| 亚洲国产欧美人成| 国产欧美日韩一区二区三区在线 | 热re99久久精品国产66热6| 免费av不卡在线播放| 色哟哟·www| 香蕉精品网在线| 九九在线视频观看精品| 精品一区在线观看国产| 丝袜喷水一区| 99热国产这里只有精品6| 国内精品宾馆在线| 成人亚洲精品一区在线观看 | 一边亲一边摸免费视频| 国产精品女同一区二区软件| 中文欧美无线码| 美女主播在线视频| av在线天堂中文字幕| 干丝袜人妻中文字幕| 日本熟妇午夜| 欧美日韩精品成人综合77777| 免费观看性生交大片5| 中文字幕制服av| 亚洲色图av天堂| 成人国产麻豆网| 深爱激情五月婷婷| 亚洲综合精品二区| 国产日韩欧美在线精品| av网站免费在线观看视频| 久久人人爽人人爽人人片va| 国产老妇伦熟女老妇高清| 国产大屁股一区二区在线视频| 欧美最新免费一区二区三区| 成人国产麻豆网| 超碰av人人做人人爽久久| 免费看av在线观看网站| h日本视频在线播放| 久久久久久久久大av| 最近手机中文字幕大全| 亚洲av成人精品一区久久| 天天躁夜夜躁狠狠久久av| 国产精品爽爽va在线观看网站| 国产老妇伦熟女老妇高清| 成人一区二区视频在线观看| 成人毛片a级毛片在线播放| 午夜激情久久久久久久| 男男h啪啪无遮挡| 女的被弄到高潮叫床怎么办| 色网站视频免费| 一级片'在线观看视频| 国产中年淑女户外野战色| 日韩电影二区| 日本黄大片高清| 国产男人的电影天堂91| 91在线精品国自产拍蜜月| 欧美日韩亚洲高清精品| 国产毛片a区久久久久| 久久精品久久久久久噜噜老黄| 91精品伊人久久大香线蕉| 久久精品国产鲁丝片午夜精品| 免费av不卡在线播放| 3wmmmm亚洲av在线观看| 国产免费视频播放在线视频| 女人被狂操c到高潮| 小蜜桃在线观看免费完整版高清| 少妇丰满av| 好男人视频免费观看在线| 亚洲不卡免费看| 日韩在线高清观看一区二区三区| 少妇人妻 视频| 欧美zozozo另类| 在线亚洲精品国产二区图片欧美 | 人妻制服诱惑在线中文字幕| 五月伊人婷婷丁香| 一本久久精品| 欧美高清成人免费视频www| 亚洲国产av新网站| 丝袜脚勾引网站| 国产毛片a区久久久久| 一边亲一边摸免费视频| 女的被弄到高潮叫床怎么办| 我的老师免费观看完整版| 啦啦啦中文免费视频观看日本| 欧美一级a爱片免费观看看| 亚洲欧美精品专区久久| 丰满少妇做爰视频| 18+在线观看网站| 精品一区二区免费观看| 免费在线观看成人毛片| .国产精品久久| 少妇的逼好多水| 美女内射精品一级片tv| 亚洲av中文字字幕乱码综合| 日韩成人av中文字幕在线观看| 极品少妇高潮喷水抽搐| 男的添女的下面高潮视频| 久久精品综合一区二区三区| 亚洲精品456在线播放app| 精品少妇黑人巨大在线播放| 五月伊人婷婷丁香| 亚洲国产精品成人综合色| 国产综合懂色| 国产精品一区二区性色av| 亚洲最大成人av| 亚洲国产精品国产精品| 在线看a的网站| 听说在线观看完整版免费高清| 美女高潮的动态| .国产精品久久| 在线观看三级黄色| 国产 精品1| 小蜜桃在线观看免费完整版高清| 亚洲欧美日韩无卡精品| 大片免费播放器 马上看| 夜夜爽夜夜爽视频| 中文字幕av成人在线电影| 超碰av人人做人人爽久久| videos熟女内射| 神马国产精品三级电影在线观看| 久久6这里有精品| 亚洲在线观看片| 日韩欧美 国产精品| 欧美性感艳星| 三级国产精品片| 精品少妇黑人巨大在线播放| 少妇丰满av| 少妇熟女欧美另类| 一个人看的www免费观看视频| 少妇的逼好多水| 成年免费大片在线观看| 老司机影院毛片| 七月丁香在线播放| 国模一区二区三区四区视频| 国产日韩欧美在线精品| 国产午夜精品久久久久久一区二区三区| 午夜福利视频精品| 国产在线一区二区三区精| 国产精品一区二区性色av| 麻豆国产97在线/欧美| 99热6这里只有精品| 亚洲精品一二三| 2022亚洲国产成人精品| 精品少妇久久久久久888优播| av在线老鸭窝| 久久久久久九九精品二区国产| 夫妻午夜视频| 久久久久性生活片| 黄色配什么色好看| 国产伦精品一区二区三区视频9| 色婷婷久久久亚洲欧美| 特级一级黄色大片| 最近最新中文字幕免费大全7| 性色avwww在线观看| 亚洲无线观看免费| 久久精品国产自在天天线| 免费观看的影片在线观看| 日韩在线高清观看一区二区三区| 97人妻精品一区二区三区麻豆| 国产精品熟女久久久久浪| 亚洲精华国产精华液的使用体验| 久久久久精品久久久久真实原创| 成年人午夜在线观看视频| 欧美老熟妇乱子伦牲交| 精品人妻视频免费看| 成人无遮挡网站| 亚洲人成网站在线观看播放| 精品一区二区免费观看| 欧美 日韩 精品 国产| av.在线天堂| 一级毛片久久久久久久久女| 少妇人妻精品综合一区二区| 亚洲国产精品999| 精品国产乱码久久久久久小说| 日本欧美国产在线视频| 国产成人一区二区在线| 精品国产三级普通话版| 国产精品一区www在线观看| 在线a可以看的网站| a级毛片免费高清观看在线播放| 男人狂女人下面高潮的视频| 亚洲欧美精品自产自拍| 欧美日韩视频高清一区二区三区二| 国产成人a区在线观看| 精品国产乱码久久久久久小说| 最后的刺客免费高清国语| 80岁老熟妇乱子伦牲交| 久久久久久伊人网av| 亚洲精品日本国产第一区| 欧美激情久久久久久爽电影| 搡女人真爽免费视频火全软件| 亚洲成人久久爱视频| 高清午夜精品一区二区三区| 精品少妇久久久久久888优播| 乱码一卡2卡4卡精品| 久久精品人妻少妇| 欧美成人a在线观看| 高清视频免费观看一区二区| 亚洲欧美成人综合另类久久久| 在线免费十八禁| 国产熟女欧美一区二区| 夫妻午夜视频| 久久久久久久久久久丰满| 91午夜精品亚洲一区二区三区| 一个人观看的视频www高清免费观看| 91精品一卡2卡3卡4卡| 少妇人妻久久综合中文| 久久久久国产精品人妻一区二区| 国产精品一区二区在线观看99| 久久影院123| 丝袜喷水一区| 国产一区二区三区av在线| 国产人妻一区二区三区在| 看十八女毛片水多多多| 搡老乐熟女国产| 夜夜爽夜夜爽视频| 一区二区av电影网| 国产精品一二三区在线看| 大香蕉久久网| 又粗又硬又长又爽又黄的视频| 国产精品蜜桃在线观看| 天堂中文最新版在线下载 | 国产在视频线精品| 国产一区二区三区综合在线观看 | 日韩欧美 国产精品| 在线观看美女被高潮喷水网站| 最近最新中文字幕大全电影3| 日本与韩国留学比较| 国产老妇伦熟女老妇高清| 看免费成人av毛片| 青春草亚洲视频在线观看| 日日啪夜夜爽| 男女边摸边吃奶| 国语对白做爰xxxⅹ性视频网站| 国产精品一区二区在线观看99| 欧美激情在线99| 人妻 亚洲 视频| 亚洲综合色惰| 久久精品国产亚洲网站| av在线蜜桃| 好男人视频免费观看在线| 日本熟妇午夜| 麻豆成人午夜福利视频| 国产熟女欧美一区二区| 欧美成人a在线观看| 国产成人精品福利久久| av国产精品久久久久影院| 人妻一区二区av| 成人漫画全彩无遮挡| 国产欧美日韩精品一区二区| 久久久久久久久大av| 久热久热在线精品观看| 国产精品无大码| 亚洲国产色片| 黄色配什么色好看| 免费大片18禁| 成人一区二区视频在线观看| 久久久久久伊人网av| 欧美丝袜亚洲另类| 高清午夜精品一区二区三区| 国产成人免费无遮挡视频| 亚洲在久久综合| 亚州av有码| 下体分泌物呈黄色| 国产欧美亚洲国产| 欧美国产精品一级二级三级 | 少妇高潮的动态图| 久久久久久国产a免费观看| 日本一本二区三区精品| 男女下面进入的视频免费午夜| 99热全是精品| 天天躁夜夜躁狠狠久久av| 久久国内精品自在自线图片| 看免费成人av毛片| 亚洲av电影在线观看一区二区三区 | 国产欧美亚洲国产| 欧美少妇被猛烈插入视频| 国产成人a区在线观看| 国产成人免费观看mmmm| 久久精品国产a三级三级三级| 国产精品偷伦视频观看了| 国产精品一区www在线观看| 边亲边吃奶的免费视频| 热99国产精品久久久久久7| 久久久久国产网址| 欧美一区二区亚洲| 亚洲av成人精品一区久久| 永久免费av网站大全| 插阴视频在线观看视频| 五月开心婷婷网| 久久精品久久精品一区二区三区| 内射极品少妇av片p| 91在线精品国自产拍蜜月| 久久精品国产亚洲av涩爱| 美女xxoo啪啪120秒动态图| 色5月婷婷丁香| 日韩强制内射视频| 精品久久久久久久人妻蜜臀av| 自拍欧美九色日韩亚洲蝌蚪91 | 天美传媒精品一区二区| 久久精品熟女亚洲av麻豆精品| 国内揄拍国产精品人妻在线| 欧美 日韩 精品 国产| av免费观看日本| 国产成人aa在线观看| 欧美三级亚洲精品| 亚洲高清免费不卡视频| 国产白丝娇喘喷水9色精品| 69人妻影院| 欧美人与善性xxx| 国产精品精品国产色婷婷| 黄色欧美视频在线观看| 亚洲精品色激情综合| 最近最新中文字幕大全电影3| 亚洲国产av新网站| 国产爽快片一区二区三区| av免费观看日本| 女人被狂操c到高潮| 中文欧美无线码| 如何舔出高潮| 亚洲自拍偷在线| 天堂俺去俺来也www色官网| 国产黄频视频在线观看| a级毛色黄片| 国产黄色免费在线视频| 午夜激情福利司机影院| 免费看a级黄色片| 欧美3d第一页| 亚洲真实伦在线观看| 国产黄色视频一区二区在线观看| 精品人妻偷拍中文字幕| 免费黄色在线免费观看| 在线观看av片永久免费下载| 丝袜脚勾引网站| 寂寞人妻少妇视频99o| 久久久久网色| 我的老师免费观看完整版| 水蜜桃什么品种好| 国内少妇人妻偷人精品xxx网站| 久久久久网色| 一个人看视频在线观看www免费| 精品午夜福利在线看| 一级爰片在线观看| 亚洲欧美日韩无卡精品| 免费观看的影片在线观看| 夜夜看夜夜爽夜夜摸| 2021少妇久久久久久久久久久| 永久网站在线| 中文乱码字字幕精品一区二区三区| 午夜福利网站1000一区二区三区| 中文乱码字字幕精品一区二区三区| 交换朋友夫妻互换小说| 最近2019中文字幕mv第一页| 91午夜精品亚洲一区二区三区| 国产中年淑女户外野战色| 亚洲精品自拍成人| 午夜爱爱视频在线播放| 男的添女的下面高潮视频| 少妇 在线观看| 国产真实伦视频高清在线观看| 久久99热6这里只有精品| 欧美日韩视频精品一区| 一级av片app| 精华霜和精华液先用哪个| 超碰97精品在线观看| 黄片无遮挡物在线观看| 热re99久久精品国产66热6| 国产 一区精品| 美女视频免费永久观看网站| 美女主播在线视频| 中文字幕免费在线视频6| 少妇丰满av| 极品少妇高潮喷水抽搐| 成人漫画全彩无遮挡| 肉色欧美久久久久久久蜜桃 | 免费播放大片免费观看视频在线观看| 亚洲av中文字字幕乱码综合| 欧美xxxx黑人xx丫x性爽| 蜜臀久久99精品久久宅男| 免费黄频网站在线观看国产| 黄色怎么调成土黄色| 三级国产精品欧美在线观看| 久久久久久久国产电影| 国国产精品蜜臀av免费| 亚洲成人av在线免费| 韩国高清视频一区二区三区| 国产成年人精品一区二区| 亚洲欧美日韩东京热| 好男人在线观看高清免费视频| 久久精品国产自在天天线| 日韩欧美一区视频在线观看 | av国产精品久久久久影院| 交换朋友夫妻互换小说| 99久久人妻综合| 欧美性猛交╳xxx乱大交人| 精品熟女少妇av免费看| 美女视频免费永久观看网站| 一级a做视频免费观看| 波野结衣二区三区在线| 久久99热6这里只有精品| xxx大片免费视频| 国产精品一区二区三区四区免费观看| 国产黄色视频一区二区在线观看| 日日撸夜夜添| 免费看光身美女| 午夜爱爱视频在线播放| 亚洲综合色惰| 日韩国内少妇激情av| 乱系列少妇在线播放| 免费av毛片视频| 久久精品国产亚洲av涩爱| 简卡轻食公司| 日日撸夜夜添| 亚洲欧美日韩东京热| 欧美xxxx性猛交bbbb| 一本—道久久a久久精品蜜桃钙片 精品乱码久久久久久99久播 | 黑人高潮一二区| 少妇高潮的动态图| 青春草国产在线视频| 中文精品一卡2卡3卡4更新| h日本视频在线播放| 成年免费大片在线观看| 特大巨黑吊av在线直播| 国产精品三级大全| 99视频精品全部免费 在线| 嘟嘟电影网在线观看| 欧美国产精品一级二级三级 | 亚洲色图av天堂| 久久99热6这里只有精品| 久久人人爽人人爽人人片va| 免费av不卡在线播放| 又爽又黄无遮挡网站| 一级a做视频免费观看| 精品国产露脸久久av麻豆| 晚上一个人看的免费电影| 91久久精品国产一区二区三区| 成年女人看的毛片在线观看| 熟妇人妻不卡中文字幕| 深爱激情五月婷婷| 男的添女的下面高潮视频|